Is there scope for checking serum biochemistry in the epilepsy clinic?

In clinical practice, blood tests are frequently ordered without a clear rationale or clinical context. This approach may lead to missed opportunities for meaningful interpretation of results. Established knowledge shows that neurological symptoms can be influenced by biochemical imbalances. However, the relevance of routine serum biochemistry in epilepsy remains unclear. Prior research has shown that hypocalcaemia is less commonly encountered than hypercalcaemia. No prior work had resolved whether such testing is essential in first-fit clinics. This gap motivated a closer examination of clinical scenarios where biochemistry may play a role. The discussion explores whether such investigations are justified in routine epilepsy care.

The aim of this case discussion is to evaluate the role of serum biochemistry in the assessment of first-fit patients. A specific problem arises when abnormal blood tests are found unexpectedly. The motivation stems from the lack of clear evidence supporting the routine use of these tests. The authors seek to highlight a scenario where biochemical findings influenced clinical decisions. This includes the discontinuation of antiepileptic drugs once hypocalcaemia was corrected. The discussion centers on whether such investigations are clinically relevant. The authors propose that these tests may be useful in some cases but lack strong evidence for routine use. This paper aims to provoke further discussion on the topic.

The study presents a single clinical case involving a patient with two generalised tonic-clonic seizures. Routine blood tests were performed in the First Fit clinic, revealing hypocalcaemia. The patient was investigated for the cause of this biochemical abnormality. 1-alphahydroxycholecaliferol was administered as treatment. The patient’s antiepileptic drug was discontinued after calcium levels improved. The authors reviewed the possible causes of hypocalcaemia in the context of epilepsy. The discussion is based on clinical observation and literature review. The authors do not use statistical analysis or large-scale data.

The patient presented with generalised tonic-clonic seizures and hypocalcaemia. No prior work had resolved the significance of this finding in first-fit clinics. The hypocalcaemia was corrected with 1-alphahydroxycholecaliferol. Antiepileptic drug therapy was stopped after calcium levels normalised. The authors suggest that the seizures may have been symptomatic of the biochemical abnormality. The discussion highlights the rarity of hypocalcaemia compared to hypercalcaemia. No strong evidence supports routine biochemistry testing in first-fit clinics. The case illustrates the potential relevance of such investigations in some patients.

The authors propose that serum biochemistry may have a role in first-fit clinics but lacks strong evidence for routine use. The case suggests that biochemical abnormalities may be linked to seizure presentation. No prior work had resolved whether such testing is essential in all patients. The authors suggest that investigations should be guided by clinical context. The discussion highlights the need for further research on this topic. The authors do not claim that these tests are essential for all patients. The findings suggest that hypocalcaemia may present with seizure-like symptoms. The authors conclude that the relevance of these tests remains uncertain in routine practice.